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Fibroblast growth factor receptors and their ligands in the adult Fibroblast growth factors (FGFs) are heparin-binding
rat kidney. proteins involved in many biological processes during
Background. Fibroblast growth factors (FGFs) are a family embryonic development and homeostasis in the adultof at least 21 heparin-binding proteins involved in many biolog-
[1]. The FGF family has at least 21 members [2], onlyical processes, both during development and in the adult, in-
some of which have been examined in the kidney. FGF-1cluding cell proliferation, differentiation, and angiogenesis. FGFs
mediate their effects through high-affinity tyrosine kinase recep- and FGF-2 are present in both adult and embryonic
tors (FGFRs), which are encoded by four genes. The aims of kidneys, and crude kidney extracts have mitogenic and
the present study were to localize FGFR-1 through FGFR-3 in
angiogenic activity caused by FGF-2 [3]. An alternatethe normal adult rat kidney and to determine which functional
transcript for FGF-1 is specifically expressed in kidneyFGFR variants and FGFs were expressed.
Methods. Avidin-biotin–enhanced horseradish peroxidase [4]. FGF-2 protein and mRNA have been localized in
immunohistochemistry was used on paraffin sections of rat human kidneys [5], and we have previously shown that
kidney to localize FGFR-1 through FGFR-3, whereas reverse FGF-1 and FGF-2 proteins are colocalized in glomeruli,transcriptase-polymerase chain reaction was used to examine
S3 segments of proximal tubules, distal tubules, and col-expression of the receptor variants and also of FGF-1 through
FGF-10 in cortex, outer medulla, and inner medulla. lecting ducts of adult rat kidneys [6]. In adult rat kidneys,
Results. By immunohistochemistry, each receptor was local- FGF-7 mRNA has been localized by in situ hybridization
ized to distinct and overlapping nephron segments, such that to medullary interstitial cells [7]. FGF-8 mRNA was de-one or more FGFRs were localized to all nephron and collecting
tected by reverse transcriptase-polymerase chain reac-duct epithelia. FGFR-1 and FGFR-3 were localized to glomer-
tion (RT-PCR) [8], and high levels of FGF-9 mRNAuli, FGFR-3 to proximal tubules and FGFR-1 to thin limbs.
FGFR-1 through FGFR-3 were localized to distal straight tu- were detected by Northern analysis [9].
bules, with FGFR-1 and FGFR-3 localized to distal convoluted Four genes encode the FGF receptors (FGFRs), which
tubules. FGFR-1 and FGFR-3 were localized to medullary col-
are characterized by three extracellular immunoglobu-lecting ducts. In addition, FGFR-1 was localized to the smooth
lin-like loops, a transmembrane domain, and a split tyro-muscle of renal arteries. All seven FGFR variants were expressed
in the cortex and outer medulla, with fewer FGFRs in the sine kinase domain [10]. Alternative mRNA splicing of
inner medulla. FGF-1, FGF-2, FGF-7, FGF-8, and FGF-9 were loop III of FGFR-1 through FGFR-3 leads to distinct
expressed in the kidney, with FGF-10 expression found only functional variants (IIIb and IIIc) that have differentin the cortex.
ligand-binding affinities [11, 12]. FGFR-4 does not haveConclusions. Mapping of these receptors is critical to the
determination of the effects of FGF ligands in discrete regions alternative splicing but is most similar to an IIIc-like
of the kidney. The distributions of the FGFRs in the normal domain [13]. Therefore, the four FGFR genes can gener-
adult kidney and the restricted expression of FGF ligands sug- ate seven functional FGFR variants. The ligand-receptorgest that specific FGFs have distinct and important roles in the
variant-binding interactions have been determined formaintenance of normal kidney structure and function.
FGF-1 through FGF-10 [11, 12].
Although several studies have examined the expres-
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sion and localization of FGFRs in developing kidneysbinding proteins, cell proliferation, tyrosine kinase receptors, receptor
mapping, nephron structure. [14–22], little is known about their distribution in the
adult kidney. Expression of mRNAs for FGFR-1 [20,Received for publication October 6, 1999
23, 24], FGFR-2 [24], FGFR-3 [24, 25], and FGFR-4 [16,and in revised form November 20, 2000
Accepted for publication February 16, 2001 18, 24] has been detected in the adult kidney by RT-
PCR, Northern analysis, or RNase protection analysis. 2001 by the International Society of Nephrology
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FGFR-1 protein has been localized to tubules of human monwealth Serum Laboratories) for 30 minutes at room
temperature. Sections were then treated with 3% H2O2kidney [26], and that of FGFR-2 IIIb to tubular epithe-
in methanol for 15 minutes to remove endogenous perox-lium and papilla of adult rat kidney [7]. All four receptors
idase activity. After blocking for one hour, primary anti-have been localized to the tubule epithelium of human
bodies were incubated on sections overnight at 4C. Anti-kidney, but without description of the tubule types [27].
bodies were detected by incubation with biotinylatedMost recently, Floege et al have found FGFR-1 protein
secondary antibody (Vector Laboratories, Burlingame,and mRNA in glomeruli, loops of Henle, distal tubules,
CA, USA) for one hour, followed by incubation withand collecting ducts of human kidney [5].
avidin-biotin horseradish peroxidase complex (VectastainExpression of FGFR variants has been determined by
Elite ABC kit; Vector Laboratories) for one hour andRT-PCR in adult rat kidney [24]. All seven functional
reacted to color with diaminobenzidine (Zymed Labora-FGFR variants were expressed in the cortex, but only the
tories, South San Francisco, CA, USA). Immunohisto-IIIc isoforms of FGFR-1 through FGFR-3 and FGFR-4
chemistry was repeated at least three times on kidneywere expressed in glomeruli. The aims of the present
sections from each rat dissected.study were to report the localization of FGFR-1, FGFR-2,
Affinity-purified rabbit polyclonal antibodies raised toand FGFR-3 in the normal adult rat kidney and to deter-
peptides mapping at the carboxy-terminus of FGFR-1
mine which of their functional variants and their ligands (residues 808 to 822 of the human flg gene product),
FGF-1 through FGF-10 were expressed in three regions FGFR-2 (residues 805 to 821 of the human bek gene
of the kidney: cortex, outer medulla, and inner medulla. product), and FGFR-3 (residues 792 to 806 of human
Mapping of these receptors is critical to the determina- FGFR-3) were purchased from Santa Cruz Biotechnol-
tion of the effects of FGF ligands in discrete regions of ogy (Santa Cruz, CA, USA) and used at 0.5 g/mL. Each
the kidney and is essential for investigations into the FGFR antibody is rat reactive and was tested by immu-
role of FGFs in renal disease [28]. noprecipitation and Western blotting by Santa Cruz Bio-
technology, and cross-reactivity with other FGFRs was
not detected. The peptide sequences used to generateMETHODS
these antibodies are 93% similar to rat for FGFR-1,
Animals identical to rat for FGFR-2, 79% similar to mouse for
Three female Sprague-Dawley rats were anesthetized FGFR-3 (no sequence data for rat FGFR-3 are available
with an intraperitoneal injection of pentobarbitone so- for this region). Control sections in the present study
dium (Nembutal; Boehringer Ingelheim, Artarmon, NSW, were incubated with rabbit serum (Sigma Chemical Co.,
St. Louis, MO, USA) or with antibodies that had beenAustralia) at 5 mg/100 g body weight. A midline abdomi-
preabsorbed with 5 g/mL immunizing peptides (Santanal incision was made, and the abdominal aorta was
Cruz Biotechnology).located. Kidneys were cleared with Hank’s buffered salt
solution (HBSS; Commonwealth Serum Laboratories,
RT-PCRMelbourne, Victoria, Australia) by retrograde perfusion
Reverse transcriptase-polymerase chain reaction wasthrough the abdominal aorta via a 21G hypodermic nee-
performed as described previously [22, 24] on kidneydle at 180 mm Hg. An outlet for the perfusate was pro-
segments from three female Sprague-Dawley rats. Fol-vided by an incision in the inferior vena cava. Kidneys
lowing perfusion with Hank’s buffer as described pre-were excised for RNA extraction or perfusion-fixed with
viously in this article, kidneys were excised from theBouin’s fixative for immunohistochemistry. The animals
animal, decapsulated, and sliced into 2 to 3 mm segments.were then killed by cutting open the diaphragm and
Areas of cortex, outer medulla, and inner medulla wereheart. Bouin’s perfused kidneys were then dissected from
dissected with the aid of a stereomicroscope and snapthe animal, decapsulated, sliced into 2 to 3 mm segments,
frozen prior to isolation of RNA. RT-PCR was performedand immersion-fixed in Bouin’s fixative for a further two
in duplicate to determine the expression of the FGFR-1
hours. Kidney slices were rinsed in 70% ethanol and through FGFR-3 variants using primers described by
processed to paraffin, and 3 m serial sections were cut. Ford et al [24], and of FGF-1 through FGF-10 using
All animal experiments were approved by the University primers described in Cancilla, Ford-Perriss, and Bertram
of Melbourne Animal Experimentation Ethics Commit- [22] in these specific kidney segments. Controls for RT-
tee and were in accordance with the Australian Code of PCR omitted the reverse transcriptase (non-RT control)
Practice for the Care and Use of Animals for Scientific or RNA (H2O control), which were replaced with water.
Purposes.
RESULTSImmunohistochemistry
ImmunohistochemistryImmunohistochemistry was performed as previously
described [29]. Briefly, sections were dewaxed, rehy- FGFR-1. Immunostaining for FGFR-1 was observed
in several structures in the adult rat kidney (Fig. 1 A–E).drated, and digested in 0.02% trypsin solution (Com-
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Fig. 1. Immunolocalization of fibroblast growth
factor receptor-1 (FGFR-1; A–E), FGFR-2
(G–K), and FGFR-3 (M–Q) in the adult rat
kidney. (A) Immunostaining for FGFR-1 was
observed in glomeruli, Bowman’s capsule, and
distal tubules (dt). (B) FGFR-1 immunoreac-
tivity was observed in distal tubules (dt) and
arterioles (a) but not proximal tubules (pt).
(C) In the outer stripe of the outer medulla
(OSOM), FGFR-1 was localized to distal
straight tubules (dt), with some staining in
collecting ducts (cd), but not in S3 segments
of proximal tubules (pt). (D) In the inner
stripe of the outer medulla (ISOM), FGFR-1
was localized to thin limbs of Henle’s loops
(th), collecting ducts (cd), and distal straight
tubules (dt). (E) In the inner medulla, FGFR-1
was localized to collecting ducts (cd) and thin
limbs of Henle’s loops (th). (F ) No immuno-
staining was observed using FGFR-1 preab-
sorbed with immunizing peptide, inner me-
dulla shown. (G) FGFR-2 immunoreactivity
was localized to tubules in contact with glo-
meruli, but not in glomeruli or Bowman’s cap-
sule. (H) In the cortex, FGFR-2 was localized
to tubules, including proximal (pt) and distal
tubules (dt) in contact with arterioles (a). (I)
In the OSOM, FGFR-2 immunostaining be-
came evident in distal straight tubules (dt); no
immunostaining was detected in S3 segments
of proximal tubules (pt) or collecting ducts
(cd). (J) Strong immunostaining was localized
to the basal aspect of distal straight tubules
(dt) in the ISOM but not in thin limbs of
Henle’s loops (th) or collecting ducts (cd). (K)
No immunostaining for FGFR-2 was observed
in collecting ducts (cd) or thin limbs of Henle’s
loops (th). (L) No immunostaining was ob-
served using FGFR-2 preabsorbed with im-
munizing peptide, glomerulus shown. (M)
FGFR-3 immunoreactivity was localized to
glomeruli, Bowman’s capsule, and S1 segments
of proximal convoluted tubules (pt). (N) In
the cortex, FGFR-3 immunostaining was seen
in proximal (pt) and distal tubules (dt), but
not in collecting ducts (cd). (O) In the OSOM,
FGFR-3 was localized to distal straight tu-
bules (dt), but not S3 segments of proximal
tubules (pt) or collecting ducts (cd). (P) In the
ISOM, FGFR-3 was localized to distal straight
tubules (dt), faint staining to collecting ducts
(cd), and no staining to thin limbs of Henle’s
loops (th). (Q) In the upper third of the inner
medulla, FGFR-3 was localized to a subset
of cells within collecting ducts (cd), but no
staining was observed in thin limbs of Henle’s
loops (th). (R) No immunostaining was ob-
served using FGFR-3 preabsorbed with im-
munizing peptide, ISOM shown. Bar 50m.
In the cortex, cytoplasmic FGFR-1 immunoreactivity cyte cell bodies and the parietal epithelium of Bowman’s
capsule (Fig. 1A).was detected in glomeruli, distal tubules (distal straight
tubule, macula densa, and distal convoluted tubules), In the outer medulla, FGFR-1 immunoreactivity was
observed in distal straight tubules and thin limbs ofand connecting tubules (Fig. 1 A, B). Immunostaining
was also observed in arterioles (Fig. 1B). No immuno- Henle’s loops (Fig. 1 C, D). In the outer stripe of the
outer medulla (OSOM), no immunoreactivity for FGFR-1reactivity was localized to proximal convoluted tubules,
collecting ducts, or the interstitium of the cortex (Fig. was observed in S3 segments of proximal tubules (Fig.
1C). A gradual increase in immunoreactivity for FGFR-11B). In glomeruli, FGFR-1 was localized mostly to podo-
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Fig. 2. Schema of the nephron representing
the segmental distribution of FGFRs in the
adult rat kidney. Regions indicated are cortex,
outer stripe of the outer medulla (OSOM), in-
ner stripe of the outer medulla (ISOM), and
inner medulla (IM). Shading indicates immuno-
staining for FGFR-1, FGFR-2, and FGFR-3.
Shading around glomerulus indicates immu-
nostaining in adjacent tubules. Immunostain-
ing of larger blood vessels and specific glomer-
ular cell types is not indicated.
was observed in collecting ducts from the outer medulla and infolding of the cell membrane occurs (Fig. 1M);
this staining decreased in S2 segments (Fig. 1N) and wasto the inner medulla; in the papilla, FGFR-1 immuno-
reactivity was evident in the cytoplasm and cell mem- absent from S3 segments in the OSOM (Fig. 1O). In
glomeruli, FGFR-3 appeared to be localized to severalbranes of collecting duct cells and was also observed in
thin limbs (Fig. 1E). No FGFR-1 immunoreactivity was cell types including podocytes and Bowman’s capsule
(Fig. 1M). Cytoplasmic immunostaining for FGFR-3 wasdetected in medullary capillaries or interstitial cells. Pre-
absorption of FGFR-1 antibodies with the immunizing observed in connecting tubules, distal convoluted tu-
bules, and distal straight tubules. In the ISOM, FGFR-3peptide abolished the immunostaining pattern observed
for FGFR-1 (Fig. 1F). A summary of the immunolocali- immunoreactivity was prominent in the basal aspect of
distal straight tubules (Fig. 1P). In collecting ducts,zation of FGFR-1 is shown in Figure 2.
FGFR-2. Immunostaining for FGFR-2 (Fig. 1 G–K) FGFR-3 was not localized to cortical collecting ducts or
those in the OSOM (Fig. 1 N, O), but weak immunostain-in the adult rat kidney was different to that of FGFR-1.
In the cortex, FGFR-2 immunoreactivity was detected in ing was observed in collecting ducts of the ISOM and
inner medulla (Fig. 1 P, Q). Distinct cytoplasmic and mem-the basal aspect of tubules in contact with glomeruli
(Fig. 1G) or in contact with blood vessels (Fig. 1H). The brane staining was seen in collecting ducts of the upper
third of the inner medulla; this staining was restrictedglomeruli themselves did not appear to be immunoreac-
tive for FGFR-2. The basal compartment of distal to particular cells within these tubules (Fig. 1Q) and may
represent a subpopulation of intercalated cells. No immu-straight tubule cells was immunoreactive; this staining
stopped abruptly at the border between distal straight noreactivity for FGFR-3 was seen in thin limbs, interstitial
cells, or blood vessels. Preabsorption of FGFR-3 anti-tubules and thin ascending limbs. FGFR-2 immunoreac-
tivity was particularly evident in distal straight tubules bodies with FGFR-3 immunizing peptide eliminated the
immunostaining pattern observed for FGFR-3 (Fig. 1R).of the inner stripe of the outer medulla (ISOM); these
cells have numerous basal infoldings of the cell mem- A summary of the immunolocalization of FGFR-3 is
brane (Fig. 1 I, J). FGFR-2 immunostaining was not shown in Figure 2.
observed in cortical or medullary collecting ducts (Fig.
RT-PCR1K), in the interstitium, or in blood vessels of the adult
rat kidney. Preabsorption of FGFR-2 antibodies with FGFR variants. RT-PCR showed that all of the func-
tional variants of FGFR-1 through FGFR-3 were ex-the immunizing peptide eliminated the immunostaining
pattern observed for FGFR-2 (Fig. 1L). A summary of pressed in the cortex and in the outer medulla of the
adult rat kidney (Fig. 3). The inner medulla did notthe immunolocalization of FGFR-2 is shown in Figure 2.
FGFR-3. Immunoreactivity for FGFR-3 (Fig. 1 M–Q) express FGFR-3 IIIc (Fig. 3) but did express all other
variants. These data are summarized in Table 1.was more widespread in the adult rat kidney than
FGFR-1 or FGFR-2. In the cortex, immunostaining for FGF-1 through FGF-10. RT-PCR for the FGF ligands
showed that FGF-1, FGF-2, FGF-7, FGF-8, and FGF-9FGFR-3 was observed in the basal aspect of S1 segments
of proximal convoluted tubules where interdigitation were expressed in the cortex, outer medulla, and inner
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Fig. 3. Southern analysis of RT-PCR products for FGFR-1 through
FGFR-3 IIIb and IIIc variants in adult rat kidney regions using mRNA
from cortex (C), outer medulla (OM), and inner medulla (IM). Cortex
served as positive control mRNA. For each segment, “” and “”
indicate the presence or absence of RT, and the water control is labeled
H2O. Low levels of FGFR-3 IIIb were detected in the inner medulla
following a longer exposure time of the autoradiograph.
Table 1. Summary of RT-PCR detection of fibroblast growth factor
receptor (FGFR) variant expression in the adult rat kidney
Outer Inner
Cortex medulla medulla
FGFR-1 IIIb   
FGFR-1 IIIc   
FGFR-2 IIIb   
FGFR-2 IIIc   
FGFR-3 IIIb   
FGFR-3 IIIc   
Fig. 4. Southern analysis of RT-PCR products for FGF-1 through
FGF-10 in adult rat kidney regions from cortex (C), outer medulla
(OM), and inner medulla (IM). Positive control (PC) mRNA from fetal
kidneys was used for all ligands except FGF-6, which used skeletal
muscle mRNA. For each segment, “” and “” indicate the presencemedulla of the adult rat kidney (Fig. 4). Low levels of
or absence of RT, and the water control is labeled H2O. Positive controlFGF-7 were detected in the inner medulla following (PC) samples were included with each experiment. Low levels of FGF-7
longer exposure time of the autoradiograph. FGF-3, were detected in the inner medulla following longer exposure time of
the autoradiograph.FGF-4, FGF-5, and FGF-6 were not expressed in any
segment (Fig. 4). FGF-10 was also expressed in the kid-
ney but only in the cortical segment (Fig. 4). These data
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Table 2. Summary of RT-PCR detection of fibroblast growth factor through FGF-9 were also expressed throughout the kid-
(FGF) expression in the adult rat kidney
ney, with FGF-10 expressed exclusively in the cortex.
Outer Inner Positive This expression profile was surprisingly broad consider-
Cortex medulla medulla control ing the different tubule and cell types present in the
FGF-1     kidney regions and suggested important roles for FGFs.
FGF-2    
Several studies have examined the localization ofFGF-3    
FGF-4     FGFR mRNA and protein. All four receptors were local-
FGF-5     ized to the tubule epithelium [27], and FGFR-1 protein
FGF-6    
was also localized to tubules of human kidney [26], al-FGF-7    
FGF-8     though the tubule types were not specified. A recent
FGF-9     study by Floege et al examined expression and localiza-
FGF10    
tion of FGFR-1 mRNA and protein in adult human
kidneys [5]; although strong expression could be de-
tected, variable levels of protein were observed. Floege
et al suggest that this discrepancy is due to low transla-are summarized in Table 2. The interactions between
tional efficiency [5]. We used the same commercial anti-the FGFRs and FGFs expressed in the adult kidney are
body against FGFR-1 in our study, but have previouslysummarized in Table 3.
determined that localization in paraffin sections is im-
proved by mild enzyme pretreatment prior to immunolo-
DISCUSSION calization [22, 29]. In the present study, FGFR-1 protein
was specifically localized to glomeruli, loops of Henle,This study demonstrates the specific localization of
FGFRs to nephrons and collecting ducts of adult rat distal tubule epithelia, and medullary collecting ducts in
the adult rat kidney and also to renal vascular smoothkidneys and the expression of specific FGFR variants
and FGF ligands in kidney segments. We show that each muscle cells. This pattern is identical to the mRNA local-
ization reported by Floege et al [5]. FGFR-1 can interactreceptor is localized to distinct and overlapping nephron
segments, such that one or more FGFRs are localized with a range of ligands (Table 3), but has a higher affinity
for FGF-1, FGF-2, and FGF-4 [11]. The localization ofto all nephron and collecting duct epithelia. FGFR-1 and
FGFR-3 are localized to glomeruli and distal convoluted FGFR-1 overlaps with the expression and localization
of FGF-2 in the human kidney [5] and with FGF-1 andtubules, FGFR-3 to proximal tubules, and FGFR-1 to
thin limbs. FGFR-1 through FGFR-3 are localized to FGF-2 in the rat kidney [6], which were also detected
in the tunica media of blood vessels. FGF-4 is not ex-distal straight tubules and medullary collecting ducts. In
addition, FGFR-1 is localized to the smooth muscle of pressed in the adult rat kidney.
There was overall agreement between the immunohis-renal arteries.
Previous data on FGFRs in the kidney are limited. In tochemistry and RT-PCR results, except for FGFR-2,
which was expressed in the medulla but not detected bythe adult rat, both variant forms of FGFR-1 mRNAs
were detected by RT-PCR and Northern analysis [20, 23]. immunohistochemistry. Also, we have previously de-
tected FGFR-2 in rat glomeruli by RT-PCR, and weakFGFR-3 mRNA was detected in mouse by RNase pro-
tection analysis [25], and high levels of FGFR-4 mRNA immunoreactivity was observed in glomeruli by immuno-
fluorescence on frozen kidney sections [24]. The factwere detected in adult mouse by Northern analysis [16, 18].
FGFR-2 protein was detected in rabbit by immunoblot that we could not detect FGFR-2 immunostaining in
glomeruli in paraffin sections may be due to differencesanalysis [30]. The antibodies used in the present study
were directed against the carboxy-terminus of the FGFR in epitope preservation or in sensitivity of the two meth-
ods. FGFR-2 IIIb mRNA has been localized to tubularprotein and therefore could not discriminate between
the IIIb and IIIc isoforms of FGFR-1 through FGFR-3. epithelium and papilla of adult rat kidney by radioactive
in situ hybridization [7] and can only interact with FGF-1,We have previously described the expression of FGFR
IIIb and IIIc isoforms in adult rat glomeruli by RT-PCR FGF-7, and FGF-10 [11, 12], whereas FGFR-2 IIIc can
interact with a larger range of ligands, including FGF-2,[24]. We found that the IIIc isoforms of FGFR-1 through
FGFR-3 were expressed in normal glomeruli, while the FGF-4, and FGF-9 (Table 3). Our study found FGFR-2
protein in distal straight tubules and tubule segmentsIIIb isoforms were not. In the cortex of normal kidneys,
all seven functional FGFR variants were expressed. In adjacent to glomeruli and blood vessels, suggesting para-
crine interactions with ligands produced by Bowman’sthe present study, using RT-PCR, all FGFR-1 through
FGFR-3 variants were expressed throughout the adult capsule cells, such as FGF-1 and FGF-2 [6]. Both IIIb
and IIIc variants of FGFR-2 were expressed throughoutrat kidney except FGFR-3 IIIc, which was not expressed
in the inner medulla. We extended these findings to the the kidney, as was FGF-9, which is highly mitogenic
through FGFR-2 IIIc [11]. FGF-10, which can only actFGF ligands and found FGF-1, FGF-2, and FGF-7
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Table 3. FGF-FGFR binding and mitogenic interactions in BaF3 FGFR variant cell lines
FGF-1 FGF-2 FGF-3 FGF-4 FGF-5 FGF-6 FGF-7 FGF-8 FGF-9 FGF-10
FGFR-1 IIIb          
FGFR-1 IIIc          
FGFR-2 IIIb          
FGFR-2 IIIc          
FGFR-3 IIIb          
FGFR-3 IIIc          
FGFR-4          
This table is adapted from the studies of Ornitz et al [11] and Xu et al [12]. Symbols are: , binding pair with strong mitogenic activity; , binding pair with
mitogenic activity; , non-binding pair.
through FGFR-2 IIIb (Table 3), was expressed exclu- hypertrophy, and podocyte changes associated with focal
and segmental glomerulosclerosis [35, 36]; these changessively within the cortex.
The ligands for FGFR-3 are predominantly FGF-1, included podocyte foot process effacement and vacuola-
tion. FGF-1 protein was up-regulated in rat proximalFGF-2, and FGF-9 [11]. We have shown that FGFR-3
was localized to S1 and S2 segments of proximal tubules, tubule epithelium following nephrotoxic damage [37]
and in chronically rejected human renal allografts [27].distal tubule epithelia, and medullary collecting ducts
where FGF-9, but not FGF-1 or FGF-2, is present, sug- FGF-1, not normally present in proximal tubules [6],
may have autocrine interactions with FGFR-3 localizedgesting that FGFR-3 may be interacting with FGF-9 in
these proximal tubule segments. High levels of FGF-9 to proximal tubule cells in acute renal damage [37] and
may also cause an up-regulation of FGFR expressionmRNA are present in the adult kidney by Northern
analysis [9], and we found expression throughout the following chronic renal damage [27].
Targeted mutations of FGFR-1 are embryonic lethalkidney by RT-PCR. Intense immunostaining for FGFR-3
was observed in the basal aspects of both the S1 segments prior to kidney formation [38, 39], denying further stud-
ies. Targeted disruption of FGFR-2 IIIc is peri-implanta-of proximal convoluted tubules, and distal tubule epithe-
lia, in particular the distal straight tubules in the inner tion lethal [40]; however, transgenic mice expressing a
soluble dominant-negative FGFR-2 IIIb have severe kid-stripe of the outer medulla (ISOM), where significant
interdigitation and infolding of the cell membrane oc- ney defects [41]. The kidneys failed to develop or con-
sisted of small, disorganized organs with small glomerulicurs. In the present study, FGFR-3 protein was localized
to particular cells within collecting ducts of the upper and enlarged vacuolated tubules. Despite the expression
of FGFR-4 in the adult kidney, FGFR-4 knockout micethird of the inner medulla; only FGFR-3 IIIb was ex-
pressed in the inner medulla. The discrete localization of develop normally and have no overt organ defects [42].
Interestingly, mice that are mutant for both FGFR-3 andFGFR-3 may represent a subpopulation of intercalated
cells. Such a subpopulation that specifically stained for FGFR-4 display phenotypes (severe dwarfism and lung
abnormalities) not present in either FGFR-3 or FGFR-4epidermal growth factor has been demonstrated in the
human kidney [31]. single mutants [42], but the development and function
of their kidneys have not been described.We have previously shown that FGFR-4 was ex-
pressed in the adult rat kidney [24]. Previous studies have Several FGF knockout mice have been generated, with
varying severity of phenotypes. Knockout mice forshown that FGFR-4 was overexpressed in hypervascular
renal cell carcinoma tissues; increased FGF signaling FGF-2 [43, 44], FGF-3 [45], FGF-5 [46], and FGF-6 [47]
do not have kidney defects, suggesting that either thesethrough FGFR-4 may be associated with the increased
angiogenic activity of these tumors [32]. FGFR-4 can growth factors are not essential for kidney development
or function or that other factors can compensate for theirinteract with the ligands FGF-1, FGF-2, FGF-4, FGF-6,
FGF-8, and FGF-9 (Table 3). FGF-1, FGF-2, FGF-8 [8], loss. Close scrutiny of FGF-7 knockout mice [48] showed
a significant reduction in the number of nephrons com-and FGF-9 [9] mRNAs are expressed in the adult rat
kidney, and we found that this expression was associated pared with wild-type kidneys [49]. FGFR-2 IIIb can bind
to FGF-1, FGF-3, FGF-7, and FGF-10 [11, 12]. As abro-with the cortex and medullary regions.
There is a paucity of data on the function of FGFs gation of FGFR-2 IIIb signaling resulted in severe kidney
defects [41], FGF-1 and FGF-10 may be important fac-and FGFRs in normal kidney; however, some studies
have examined FGFs in acute and chronic models of tors in development and maintenance of the adult kidney.
Activation of FGFRs involves both ligand binding andkidney disease. Increased FGF expression has been im-
plicated in the induction and progression of glomerular heparan sulfate (HS) proteoglycans; several models have
proposed that HS:FGF:FGFR interact to promote sig-sclerosis [33, 34]. Intravenous administration of FGF-2
to rats and monkeys resulted in proteinuria, glomerular naling [10, 50–53]. The exact molecular nature of the
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growth factor family: Diversity of structure and function. Progsignaling complex remains elusive, but a recent study by
Nucleic Acid Res Mol Biol 59:135–176, 1998
Pye and Gallagher supports the binding of a monomeric 11. Ornitz DM, Xu J, Colvin JS, et al: Receptor specificity of the
fibroblast growth factor family. J Biol Chem 271:15292–15297, 1996complex of FGF and HS oligosaccharide to an FGFR
12. Xu X, Weinstein M, Li C, et al: Fibroblast growth factor receptor 2monomer to facilitate dimerization through two FGFR
(FGFR-2)-mediated reciprocal regulation loop between FGF-8
binding interfaces on the growth factor [53]. and FGF-10 is essential for limb induction. Development 125:753–
765, 1998Five different HS species with different staining pat-
13. Vainikka S, Partanen J, Bellosta P, et al: Fibroblast growthterns have been identified in rat kidney [54]. Three of
factor receptor-4 shows novel features in genomic structure, ligand
these were detected in glomerular basement membranes, binding and signal transduction. EMBO J 11:4273–4280, 1992
14. Orr-Urtreger A, Givol D, Yayon A, et al: Developmental expres-and two were localized to tubule basement membranes.
sion of two murine fibroblast growth factor receptors, flg and bek.FGF-2–binding HSPGs are localized to glomerular and
Development 113:1419–1434, 1991
tubular basement membranes [55]. We found immuno- 15. Partanen J, Makela TP, Eerola E, et al: FGFR-4, a novel acidic
fibroblast growth factor receptor with a distinct expression pattern.reactivity for FGFR-1 in the tunica media of arteries and
EMBO J 10:1347–1354, 1991arterioles of adult rat kidney. Three HS species were
16. Stark KL, McMahon JA, McMahon AP: FGFR-4, a new member
specifically localized to smooth muscle of arteries and of the fibroblast growth factor receptor family, expressed in the
definitive endoderm and skeletal muscle lineages of the mouse.arterioles [54], suggesting that they may control FGF
Development 113:641–651, 1991signaling through FGFR-1 in these cells. The decreased
17. Wanaka A, Milbrandt J, Johnson EM Jr: Expression of FGF
vascular smooth muscle contractility and low blood pres- receptor gene in rat development. Development 111:455–468, 1991
18. Korhonen J, Partanen J, Alitalo K: Expression of FGFR-4sure of FGF-2 knockout mice [43, 56] suggest that FGF-2
mRNA in developing mouse tissues. Int J Dev Biol 36:323–329,action through FGFR-1 is involved in maintenance of
1992
vascular tone. The discrete segment-specific localization 19. Peters KG, Werner S, Chen G, et al: Two FGF receptor genes
are differentially expressed in epithelial and mesenchymal tissuesof FGFRs we found in normal adult rat kidney suggests
during limb formation and organogenesis in the mouse. Develop-a role for FGFs in normal kidney function and possibly
ment 114:233–243, 1992
in tissue remodeling during injury and disease. 20. Kim EG, Kwon HM, Burrow CR, et al: Expression of rat fibroblast
growth factor receptor 1 as three splicing variants during kidney
development. Am J Physiol 264:F66–F73, 1993ACKNOWLEDGMENT
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